Zenicure Labs

Budesky Respules contain Budesonide 0.5 mg, a corticosteroid medication formulated for inhalation therapy. They are commonly prescribed for managing chronic respiratory conditions.

• Budesonide (0.5 mg per respule)

  • A glucocorticoid with strong anti-inflammatory properties.

  • Reduces swelling and irritation in the airways.

  • Helps improve breathing and prevent asthma attacks.

• Asthma: Prevents and controls chronic symptoms like wheezing and shortness of breath.

• Chronic Obstructive Pulmonary Disease (COPD): Reduces airway inflammation and improves lung function.

• Allergic airway conditions: Provides relief from persistent inflammation.

Budesky-F 200 is a combination inhalation therapy containing Formoterol (6 mcg) and Budesonide (200 mcg). It is used for long-term management of asthma and chronic obstructive pulmonary disease (COPD).

• Formoterol (6 mcg)

  • A long-acting β2-agonist (LABA).

  • Relaxes airway muscles, providing sustained bronchodilation.

  • Helps prevent wheezing, breathlessness, and nighttime asthma symptoms.

• Budesonide (200 mcg)

  • An inhaled corticosteroid (ICS).

  • Reduces airway inflammation and swelling.

  • Prevents asthma attacks and improves lung function over time.

• Asthma maintenance therapy: Controls chronic symptoms and reduces frequency of attacks.

• COPD management: Improves airflow and reduces exacerbations.

• Combination benefit: Formoterol provides quick and sustained relief, while Budesonide controls inflammation.

Duosky Respules/Inhalation Solution contain a combination of Levosalbutamol (1.25 mg) and Ipratropium Bromide (500 mcg). This dual therapy is commonly prescribed for patients with asthma, COPD (Chronic Obstructive Pulmonary Disease), and other obstructive airway diseases where both bronchodilation and symptom relief are needed.

• Levosalbutamol (1.25 mg)

  • A short-acting β2-agonist (SABA).

  • Provides rapid relief by relaxing airway muscles.

  • Helps reduce wheezing, breathlessness, and acute bronchospasm.

• Ipratropium Bromide (500 mcg)

  • An anticholinergic bronchodilator.

  • Blocks muscarinic receptors, reducing airway constriction and mucus secretion.

  • Provides sustained bronchodilation, especially useful in COPD.

• Asthma: Quick relief from acute bronchospasm.

• COPD: Improves airflow and reduces exacerbations.

• Combination benefit: Levosalbutamol acts fast, while Ipratropium provides longer-lasting bronchodilation.

• Often used in nebulizer therapy for moderate to severe symptoms.

Mucibud-600 is an effervescent tablet containing Acetylcysteine 600 mg, formulated with an orange flavor and sugar-free base. It is widely used as a mucolytic agent to help clear thick mucus from the airways and also has applications in liver protection.

• Acetylcysteine (600 mg)

  • Breaks down thick mucus in the lungs, making it easier to cough out.

  • Acts as an antioxidant, replenishing glutathione in the liver.

  • Used in certain cases of paracetamol (acetaminophen) overdose as a protective agent.

• Effervescent tablet (orange, sugar-free)

  • Dissolves in water to form a fizzy solution.

  • Pleasant taste, easier to consume.

  • Suitable for diabetic patients since it is sugar-free.

• Respiratory conditions: Chronic bronchitis, COPD, asthma, cystic fibrosis — helps loosen and clear mucus.

• Paracetamol overdose: Protects the liver by replenishing glutathione.

• Liver support: Used in some chronic liver diseases due to antioxidant properties.

Levopush 0.63 contains Levosalbutamol (0.63 mg), which is a bronchodilator medication. It is commonly prescribed for patients with asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions where airway narrowing causes breathing difficulty.

• Levosalbutamol is the active (R-enantiomer) form of Salbutamol/Albuterol.

• It acts on β2-adrenergic receptors in the lungs.

• This causes relaxation of bronchial smooth muscles → airways widen → easier breathing.

• Compared to regular Salbutamol, Levosalbutamol may cause fewer side effects (like tremors or palpitations).

• Asthma attacks (acute bronchospasm relief)

• COPD management (chronic bronchitis, emphysema)

• Exercise-induced bronchospasm

• Other obstructive airway diseases

Budesky-L is a respiratory combination medication that contains:

• Levosalbutamol (1.25 mg) – a bronchodilator that relaxes airway muscles and provides quick relief from bronchospasm.

• Budesonide (0.5 mg) – an inhaled corticosteroid that reduces airway inflammation and prevents recurrence of symptoms.

• Levosalbutamol: Acts rapidly on β2-receptors in the lungs → relaxes bronchial muscles → opens airways → immediate relief from wheezing and breathlessness.

• Budesonide: Suppresses inflammation in the airways → reduces swelling and mucus production → long-term control of asthma and COPD symptoms.

• Together, they provide dual benefit: fast relief + long-term control.

• Asthma management (both acute relief and maintenance therapy)

• Chronic Obstructive Pulmonary Disease (COPD)

• Allergic airway diseases with inflammation and bronchospasm

• Preventing exercise-induced bronchospasm in sensitive patients

Budesky-F400 Inhaler is a combination inhalation therapy that contains:

• Formoterol Fumarate 6 mcg – a long-acting β2-agonist (LABA) bronchodilator.

• Budesonide 400 mcg – an inhaled corticosteroid (ICS).

• Formoterol: Relaxes bronchial smooth muscles → widens airways → provides long-lasting relief from breathlessness and wheezing.

• Budesonide: Reduces airway inflammation → decreases swelling and mucus → prevents asthma/COPD flare-ups.

• Together, they provide dual benefit:

  • Immediate and sustained bronchodilation (Formoterol).

  • Long-term anti-inflammatory control (Budesonide).

• Asthma (moderate to severe) – for patients who need both symptom relief and inflammation control.

• Chronic Obstructive Pulmonary Disease (COPD) – to reduce exacerbations and improve breathing.

• Allergic airway diseases with persistent symptoms.

Budesky-F200 Inhaler is a combination inhalation therapy that contains:

• Formoterol Fumarate 6 mcg – a long-acting β2-agonist (LABA) bronchodilator.

• Budesonide 200 mcg – an inhaled corticosteroid (ICS).

• Formoterol: Relaxes bronchial smooth muscles → widens airways → provides sustained relief from breathlessness and wheezing.

• Budesonide: Reduces airway inflammation → decreases swelling and mucus → prevents asthma/COPD flare-ups.

• Together, they deliver dual benefit:

  • Long-lasting bronchodilation (Formoterol).

  • Anti-inflammatory control (Budesonide).

• Asthma (moderate to severe) – for patients needing both symptom relief and inflammation control.

• Chronic Obstructive Pulmonary Disease (COPD) – to reduce exacerbations and improve breathing.

• Allergic airway diseases with persistent symptoms.

Mucibud-Ab is a combination medicine containing Acebrophylline (100 mg) and Acetylcysteine (600 mg), formulated to treat chronic respiratory conditions where both bronchodilation and mucus clearance are needed.

• Acebrophylline (100 mg)

  • A bronchodilator and anti-inflammatory agent.

  • Relaxes airway muscles, reduces bronchospasm, and improves airflow.

  • Also has mucokinetic properties, helping in mucus clearance.

• Acetylcysteine (600 mg)

  • A mucolytic agent that breaks down thick mucus in the lungs.

  • Makes sputum less viscous and easier to expel.

  • Has antioxidant properties, protecting lung tissue.

• Chronic Obstructive Pulmonary Disease (COPD)

• Asthma (maintenance therapy, not rescue)

• Chronic bronchitis

• Pulmonary fibrosis and other mucus-associated lung conditions

• Respiratory infections with excessive mucus production

Budesky-F 400 is a combination inhalation therapy containing Formoterol (6 mcg) and Budesonide (400 mcg). It is prescribed for patients with moderate to severe asthma or chronic obstructive pulmonary disease (COPD) who require both long-term bronchodilation and anti-inflammatory control.

• Formoterol (6 mcg)

  • A long-acting β2-agonist (LABA).

  • Relaxes airway smooth muscles, providing sustained bronchodilation for up to 12 hours.

  • Helps prevent wheezing, breathlessness, and nighttime asthma symptoms.

• Budesonide (400 mcg)

  • An inhaled corticosteroid (ICS).

  • Reduces airway inflammation, swelling, and mucus production.

  • Prevents asthma attacks and improves lung function over time.

• Asthma maintenance therapy: Controls persistent symptoms and reduces frequency of attacks.

• COPD management: Improves airflow and reduces exacerbations.

• Combination benefit: Formoterol provides rapid and sustained relief, while Budesonide controls inflammation.

• Higher strength (400 mcg): Typically prescribed for patients who need stronger anti-inflammatory action compared to Budesky-F 200.